Corporate News – Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. (ticker ORMP) closed the trading session on Friday, 23 March 2026, at USD 4.12, reflecting a decline of 0.24 % from the previous close. The last trade recorded at 04:17 AM Central European Time.
Market Metrics
| Item | Value |
|---|---|
| Shares Outstanding | 41.6 million |
| Market Capitalisation | USD 172.6 million |
| 24‑Hour Volume | USD 349.4 thousand |
| 12‑Month Price Range | Highest: USD 5.47 (27 Aug 2026); Lowest: USD 2.09 (7 Nov 2025) |
| 200‑Day Simple Moving Average | USD 4.01 |
The stock has decreased 12.84 % since the close of the previous month.
Recent Performance of Peer Stocks
The following table summarizes the performance of selected peer companies during the same 24‑hour period:
| Company | Ticker | Price Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|---|
| Valens Semiconductor | VLN | +1.26 % | USD 1.47 | USD 172.2 million | – |
| Israel Discount Bank | DSCT.TA | –0.26 % | ILA 3,489 | ILA 13.9 bn | 11.24 |
| Ceragon Networks | CRNT | +0.50 % | USD 1.94 | USD 182.6 million | – |
| Radcom | RDCM | –0.10 % | USD 10.1 | USD 170.9 million | 24.24 |
| Compugen | CGEN | –0.93 % | USD 1.96 | USD 202.2 million | 5.93 |
Company Overview
Oramed Pharmaceuticals Inc. is a specialty pharmaceutical company headquartered in Jerusalem, Israel. The company is listed on the Nasdaq stock exchange and focuses on developing oral delivery systems. Its primary product pipeline includes orally ingestible insulin capsules for diabetes management, along with other drug and vaccine delivery technologies that utilize oral ingestion methods.
For additional information, visit the company’s website at www.oramed.com .
